title: Atrial fibrillation and anticoagulation management: a wake-up call to practitioners, patients, and policymakers.
authors.affiliation: Department of Pharmacy Services, Brigham and Women's Hospital , Boston, MA , USA.
authors.forename: John
authors.initials: J
authors.lastname: Fanikos
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D000991:Antithrombins / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy* / Q000191:economics; D001562:Benzimidazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D003362:Cost-Benefit Analysis; D000069604:Dabigatran; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D011728:Pyridones / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D018570:Risk Assessment; D000069552:Rivaroxaban; D020521:Stroke / Q000191:economics / Q000209:etiology / Q000517:prevention & control*; D013876:Thiophenes / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D015091:beta-Alanine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000191:economics
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D001562:Benzimidazoles; D009025:Morpholines; D011720:Pyrazoles; D011728:Pyridones; D013876:Thiophenes; D015091:beta-Alanine; C522181:apixaban; D014859:Warfarin; D000069552:Rivaroxaban; D000069604:Dabigatran